Alzheimer’s disease affects more than 6 million people in the United States, and there are very few FDA-approved treatments that can slow the progression of the...
During the COVID-19 pandemic, the clinical spectrum observed among people infected with SARS-CoV-2 ranged from asymptomatic carriage to death. Researchers at the Institut Pasteur, the CNRS...
Investigational Menin Inhibitor Levmenib Produces Encouraging Responses in Relapsed or Refractory Patients KMT2A– rearrange or NPM1– Mutant acute leukemia in first-in-human study of oral formulation. In...
Using a novel computational approach they developed to analyze large genetic datasets from rare disease cohorts, researchers and colleagues at the Icahn School of Medicine at...
Lack of sleep and poor sleep quality in teens multiple sclerosis (MS) in adulthood, new research suggests. In a large case-control study, adolescents who slept less...
In this interview, News Medical talks to Dr. Kate Lawrenson about the latest research detailing the molecular profile of endometriosis, helping improve treatment options for the...
Recent Comments